Literature DB >> 9192950

Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody.

M Ohtsuka1, Y Yamashita, M Doi, S Hasegawa.   

Abstract

Propylthiouracil (PTU) is known to cause vasculitis as a rare complication. We report the case of a patient who developed alveolar haemorrhage and haematuria whilst treated with PTU. The serum was positive for antineutrophil cytoplasmic antibody (ANCA) with myeloperoxidase (MPO) specificity (MPO-ANCA). All symptoms resolved completely after discontinuation of PTU. Alveolar haemorrhage or pulmonary-renal syndrome associated with antineutrophil cytoplasmic antibody with myeloperoxidase specificity may be a new complication of propylthiouracil therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192950

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Diffuse alveolar haemorrhage secondary to propylthiouracil-induced vasculitis.

Authors:  Catarina Ferreira; Teresa Costa; Ana Vieira Marques
Journal:  BMJ Case Rep       Date:  2015-02-06

2.  Antineutrophil cytoplasmic antibody-positive vasculitis associated with propylthiouracil therapy.

Authors:  S Dinmezel; C Ogus; T Ozdemir
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

3.  A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism.

Authors:  Turan Calhan; Ebubekir Senateş; Egemen Cebeci; Sayid Shafi Zuhur; Fatma Ozbakır; Uğur Görpe
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

4.  Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.

Authors:  Hua Ye; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

5.  Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement.

Authors:  Yinghua Chen; Hao Bao; Zhengzhao Liu; Haitao Zhang; Caihong Zeng; Zhihong Liu; Weixin Hu
Journal:  J Nephrol       Date:  2014-02-26       Impact factor: 3.902

6.  Churg-Strauss Syndrome following PTU Treatment.

Authors:  R A M Quax; A J G Swaak; M G A Baggen
Journal:  Int J Rheumatol       Date:  2009-03-08

7.  Propylthiouracil-induced lupus-like or vasculitis syndrome.

Authors:  Cuneyt Tetikkurt; Mehmet Yuruyen; Seza Tetikkurt; Nihal Bayar; Imran Ozdemir
Journal:  Multidiscip Respir Med       Date:  2012-07-17

8.  Propylthiouracil-induced autoimmune disease.

Authors:  Santosh Paiaulla; Pradeep Marur Venkategowda; S Manimala Rao; Banda Balaraju
Journal:  Indian J Crit Care Med       Date:  2015-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.